Every follower you have on LinkedIn is rented. An email list is the only audience you own outright. We either build yours from zero or take over the one you already have and never have time to send, on whatever platform and whatever cadence you want.
Hi Founder,
What Newsletters has produced for HealthTech executives we work with:
▋
New list from zero, or we take over yours.
You choose the cadence, we run it.
Of the list, data and archive stays yours.
Four hundred of the right readers outperform forty thousand strangers. We build the list from people who can actually buy, invest or partner.
No feed, no ranking, no reach penalty. The people you want reading your thinking receive it.
Ten thousand followers and no way to reach any of them directly the day a health system RFP opens.
The people who matter most, three health system buyers and two investors, are buried in a follower list you cannot query.
Nothing on your profile converts a reader into a contact you can follow up with.
Every post starts from zero reach instead of building on the last one.
If you already have a newsletter we audit it: list health, deliverability, open and click history, format, cadence and archive, then tell you what to keep and what to change. If you have nothing, we start from the blank page and design the publication with you.
We agree the shape of the send and how often it goes out. Daily briefing, weekly note or monthly essay. Whatever you commit to, we produce it and hit the date, because the calendar is our job and not yours.
beehiiv, Substack, Kit, Mailchimp, MailerLite, Ghost or your company's approved stack. We set it up properly, or migrate your existing list and archive across without losing subscribers, deliverability or history.
A short, genuinely useful asset only you could write: a procurement readiness checklist, a reimbursement diligence framework, a briefing on where a category actually stands commercially.
Hosted capture page, list infrastructure, consent handling and deliverability set up properly so your sends land in the inbox rather than promotions.
We research, draft, edit and schedule every issue in your voice, from your voice notes, board decks and product notes or from what is moving in your category. You approve on your phone. Daily, weekly or monthly, the standard does not drop.
Buyers, investors, press and analysts tagged separately, so a funding announcement, a case study and a commentary opportunity each go to the right subset.
We place you in newsletters your buyers and investors already read, which is the fastest legitimate way to add several hundred qualified subscribers.
Thirty minutes a month reviewing the send. The lead magnet takes one interview.
If you have no intention of ever emailing your audience, skip this and put the budget into LinkedIn and PR.
A growing LinkedIn audience with no way to contact anyone directly.
A frontline briefing on what actually happens inside health system procurement, sent monthly, with a diligence checklist as the capture asset.
A list read by health system executives and trade journalists, producing analyst briefings and expert commentary requests.
Yes. Consent is explicit, the source of every subscriber is recorded, and unsubscribe handling is built in from day one.
One call. We review your current position, tell you honestly whether Newsletters is the right channel for you, and show you the first three moves.